SAN DIEGO, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Ambrx Biopharma, Inc., or Ambrx (NASDAQ: AMAM), today announced a clinical update regarding its proprietary anti-PSMA antibody drug conjugate (ADC) ARX517 ...
Most people with prostate cancer won’t die from it. But it still kills more American men than any type of cancer except lung cancer, because prostate cancer is more common. Prostate cancer needs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback